Abata Therapeutics

Abata Therapeutics

    Company info:

  • 1-50
  • 2021
  • Cambridge, MA
  • 50-100M



Claim company profile

About company:

Abata Therapeutics is understanding the biology of T cells to create therapies for autoimmune diseases. Regulatory T cells (Tregs) are a critical component of the immune system that act to suppress the immune response preventing autoimmunity. Abata is using this knowledge to engineer Tregs as targeted therapies that stop immune-mediated destruction of normal cells and restore homeostasis. Treg engineering involves expression of a T cell receptor that recognizes a tissue-restricted antigen, to selectively target the therapy to the site of disease for a robust response. In addition, engineered Tregs are optimized for durability allowing the effects of a single dose to last years. Abata has initial programs for multiple sclerosis and Type 1 diabetes.


Abata Therapeutics
Senior Accountant (Part-Time)
Watertown, MA|5 days ago
Abata Therapeutics
Technical Operations Co-Op
Watertown, MA|5 days ago
Abata Therapeutics
Associate Scientist, Technical Operations
Watertown, MA|24 days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com